register

Mentoring

Award-winning IMNIS program fosters collaboration and innovation between industry and academia

Health Industry Hub | July 12, 2020 |

Mentoring: The Industry Mentoring Network in STEM (IMNIS) provides PhD student mentees an understanding of the industry sector, strengthen their skills to be successful within any part of the science, technology, engineering and mathematics (STEM), including health and medicine sector, and extend their professional network.

The survey, conducted by the Academy of Technology and Engineering’s (ATSE’s) IMNIS initiative, found the majority of IMNIS alumni either work in industry or are actively pursuing or considering an industry career, compared to only about 30% of PhD graduates not participating in the program.

IMNIS mentees from the pilot program in 2015/16 and subsequent national programs in 2017/18 and 2018/19 were surveyed on their attitudes towards engaging with industry. Over half of the respondents (53%) have completed their PhD.

ATSE CEO Kylie Walker said IMNIS is fostering a culture shift between industry and academia, toward more collaboration and innovation.

“It is increasing students’ understanding of a huge range of potential careers enabled by a STEM qualification, as well as showing leaders in industry the value today’s STEM PhD graduates could bring to their organisation and to building a more innovative Australian economy,” Ms Walker said.

The survey found 97% of mentees were either collaborating, keen to collaborate or were considering collaborating with industry.

A participant in the IMNIS medical technology and pharmaceuticals program in 2017-18, said while she was a PhD student she was interested in pursuing a career in industry but wasn’t sure how to transition from academia.

“The IMNIS program really helped highlight the crucial role of networking and I was fortunate enough for my mentor to introduce me to her colleagues, who are leaders in their fields,” she said.

“Networking during my PhD allowed me to connect with a wide variety of people, expand my network and helped me to understand the types of industry roles available.”

A third of mentees said the IMNIS program revealed novel ideas or had inspired them to take a new direction with their research, with 8% now working on an entirely different research project.

Almost half said that since IMNIS their research had slightly changed direction; while one-third said it had done this, with 8% now working on an entirely different research project.

Enduring networks were another benefit of the program, with more than two-thirds of IMNIS students staying in contact with their mentor after their program ended.

“I’m proud to be a mentor for the award-winning Industry Mentoring Network in STEM (IMNIS) program which breaks down barriers between industry and academia. I’m delighted to invest in Australia’s future STEM leaders and it is excellent to see IMNIS alumni mentees pursuing industry STEM careers and collaborations,” said Rozalina Sarkezians, Founder of Health Industry Hub media.

IMNIS has attracted over 500 influential industry leaders to mentor Australia’s future workforce; these include Board Chairs and Directors, C-suite executives, General Managers and Partners from small, medium and large enterprises in medical technologies, pharmaceuticals, research and development, advanced manufacturing, renewable energy, resources and related services, artificial intelligence, space, accounting and consulting, as well as several start-ups. Read the survey results


News & Trends - MedTech & Diagnostics

APAC medtech company scores TGA approval in heart disease

APAC medtech company scores TGA approval in heart disease

Health Industry Hub | October 4, 2024 |

MedTech & Diagnostics News: An Asia Pacific medtech company has announced that its flagship drug-eluting stent (DES) has received regulatory […]

More


News & Trends - MedTech & Diagnostics

New state-based pilot to back home-grown medtech innovation

New state-based pilot to back home-grown medtech innovation

Health Industry Hub | October 4, 2024 |

MedTech & Diagnostics: In a bid to enhance opportunities for local medtech manufacturers to sell to health services, a connected […]

More


News & Trends - Pharmaceuticals

Ferring unveils first real-world evidence for faecal calprotectin approach in ulcerative colitis

Ferring unveils first real-world evidence for faecal calprotectin approach in ulcerative colitis

Health Industry Hub | October 4, 2024 |

Pharma News: Ferring Pharmaceuticals has announced results from a new study, which provides the first real-world evidence supporting the efficacy […]

More


News & Trends - Pharmaceuticals

Bayer partners with RACGP, calls for MBS reforms to boost access to long-acting contraceptives

Bayer partners with RACGP, calls for MBS reforms to boost access to long-acting contraceptives

Health Industry Hub | October 4, 2024 |

Pharma News: Australian women are calling for more accurate information about their contraceptive options, with 70% feeling inadequately educated about […]

More


This content is copyright protected. Please subscribe to gain access.